Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 16 most recent Form 4 transactions.
| Marimed INC. |
| MEXER |
| 42,656 |
| — |
| — |
| +0.4% |
| Open the original filing on SEC.gov |
| May 29 | MRMD | Marimed INC. | MEXER◆ | 40,625 | — | — | — | Open the original filing on SEC.gov |
| May 29 | MRMD | Marimed INC. | FTAX | 14,077 | $0.0805 | $1.1K | -0.1% | Open the original filing on SEC.gov |
| May 29 | MRMD | Marimed INC. | MEXER | 40,625 | — | — | +0.4% | Open the original filing on SEC.gov |
| Apr 15 | MRMD | Marimed INC. | AGRANT◆ | 170,625 | — | — | — | Open the original filing on SEC.gov |
| Apr 2 | MRMD | Marimed INC. | MEXER◆ | 9,982 | — | — | — | Open the original filing on SEC.gov |
| Apr 2 | MRMD | Marimed INC. | FTAX | 3,459 | $0.0691 | $239 | <0.1% | Open the original filing on SEC.gov |
| Apr 2 | MRMD | Marimed INC. | MEXER | 9,982 | — | — | +0.1% | Open the original filing on SEC.gov |
| Mar 7 | MRMD | Marimed INC. | MEXER◆ | 21,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 7 | MRMD | Marimed INC. | FTAX | 7,508 | $0.084 | $631 | <0.1% | Open the original filing on SEC.gov |
| Mar 7 | MRMD | Marimed INC. | MEXER | 21,667 | — | — | +0.2% | Open the original filing on SEC.gov |
| Mar 1 | MRMD | Marimed INC. | MEXER◆ | 65,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 1 | MRMD | Marimed INC. | FTAX | 22,523 | $0.0848 | $1.9K | -0.2% | Open the original filing on SEC.gov |
| Mar 1 | MRMD | Marimed INC. | MEXER | 65,000 | — | — | +0.7% | Open the original filing on SEC.gov |